moxisylyte has been researched along with Urethral Diseases in 1 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Urethral Diseases: Pathological processes involving the URETHRA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Combes, T | 1 |
| Beguin, AM | 1 |
| Coulomb, Y | 1 |
| Barouti, H | 1 |
| Costa, P | 1 |
1 other study available for moxisylyte and Urethral Diseases
| Article | Year |
|---|---|
[Changes in urethral pressure after intravenous injection of moxisylyte hydrochloride in urethral instability in women. Preliminary results].
Topics: Adult; Female; Humans; Injections, Intravenous; Middle Aged; Moxisylyte; Placebos; Polyuria; Pressur | 1995 |